Clinical trial
Evaluation of the Efficacy and Effectiveness of Combined Therapy With Mefloquine and Artesunate for Uncomplicated Malaria Treatment in the Loreto Region (Amazon Basin), Peru
NCT00164216 is registered in ClinicalTrials.gov with Centers for Disease Control and Prevention as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Efficacy and Effectiveness of Combined Therapy With Mefloquine and Artesunate for Uncomplicated Malaria Treatment in the Loreto Region (Amazon Basin), Peru
- Lead sponsor
- Centers for Disease Control and Prevention
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2005
- Completion date
- March 31, 2008
- Enrollment
- 208 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
malaria falciparum